FDA Approved: LIDOCAINE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lidocaine Patch 5% from Endo USA, Inc., expanding the regulatory authorization for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Lidocaine patch 5% (Lidocaine)

Snippet

SUPPL AP for LIDOCAINE (LIDOCAINE)